DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 091555
The generic ingredient in EPTIFIBATIDE is eptifibatide. There are fifteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the eptifibatide profile page.
Summary for 091555
Tradename: | EPTIFIBATIDE |
Applicant: | Teva Pharms Usa |
Ingredient: | eptifibatide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 091555
Physiological Effect | Decreased Platelet Aggregation |
Suppliers and Packaging for NDA: 091555
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
EPTIFIBATIDE | eptifibatide | INJECTABLE;INJECTION | 091555 | ANDA | Teva Parenteral Medicines, Inc. | 0703-1179 | N | 0703-1179-01 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 75MG/100ML | ||||
Approval Date: | Jun 5, 2015 | TE: | RLD: | No |
Complete Access Available with Subscription